Wyeth (NZ) Ltd v Ancare New Zealand Ltd

Link copied
Case Copied 29 min read

For a Court ready (fee required) version please follow this link

In the Supreme Court of New Zealand

SC 57/2009
[2010] NZSC 46

BETWEEN     WYETH (NZ) LIMITED
Appellant

AND   ANCARE NEW ZEALAND LIMITED
First Respondent

AND   THE ENVIRONMENTAL RISK MANAGEMENT AUTHORITY
Second Respondent

Hearing:         8 February 2010

Court:  Elias CJ, Blanchard, McGrath, Wilson and Anderson JJ

Counsel:         B W F Brown QC and G Hazel for Appellant
J O Upton QC for First Respondent (given leave to withdraw)
D J Goddard QC and C Gregorash for Second Respondent
H M Aikman QC as Amicus Curiae

Judgment:      23 April 2010

JUDGMENT OF THE COURT

The appeal is dismissed with no order for costs.

REASONS

(Given by McGrath J)

Introduction

[1]      Ancare New Zealand Ltd, the first respondent, applied to the Environmental Risk Management Authority under the Hazardous Substances and New Organisms Act 1996 for approval to import or manufacture a veterinary medicine.  The Act requires the Authority to keep a register of all applications made to it which is available for public inspection.  The register must specify “a sufficient description” of substances the subject of application “to uniquely identify” them.

[2]       In the public section of its application Ancare used the alphanumeric codeword MEP 600 to refer to its substance.  Details of the chemical composition were provided in a confidential section.  The Authority referred to the substance on its register using the same codeword.  It took the view that this sufficiently described the substance to meet the requirements of the Act.  No specific information concerning the composition of MEP 600 was included on the register.

[3]      Wyeth (NZ) Ltd, the appellant, is a competitor of Ancare which wished to make a submission to the Authority on Ancare’s application.  Wyeth sought information from the Authority concerning the identity and chemical composition of MEP 600.  The Authority decided that disclosure of this information would unreasonably prejudice Ancare’s commercial position and refused Wyeth’s request.  The Authority then proceeded to a hearing following which it granted Ancare’s application.  Wyeth appealed against that decision to the High Court, which held that the Authority had misinterpreted the legislation and should reconsider both the application and whether Wyeth should be provided with information concerning the make-up of MEP 600.  The High Court quashed the Authority’s decision approving the application and directed the Authority to rehear it.  Ancare appealed to the Court of Appeal, which allowed the appeal and reinstated the Authority’s approval of the application.

[4]      Wyeth now appeals, with leave, to this Court against the Court of Appeal’s judgment.  The approved ground of appeal is whether the Act requires that the Authority include on its register of applications details of the composition and active ingredients of all substances concerned.  Ancare was named as respondent to the appeal but, for reasons which are unrelated to this proceeding, decided not to participate.  In those circumstances we appointed Ms Aikman QC as amicus to advance argument to us in opposition to the appeal. 

Statutory scheme

[5]      The long title of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Wyeth (NZ) Ltd v Ancare New Zealand Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2010] NZSC 46
Decision Date

CaseChat Overview and Summary

The appeal was against the Court of Appeal's reinstatement of the Authority's decision to approve an application by Ancare to import or manufacture a veterinary medicine. The issue was whether the Authority's register should include details of the composition and active ingredients of all substances concerned. The Supreme Court held that the Act did not require the Authority to disclose confidential information in the register. It was intended to provide a summary of all applications and outcomes, not a comprehensive record of information available to the Authority. The Authority's decision to withhold confidential information from the public and the register was not in error. The Court concluded that the Authority was not required by the Act to disclose details of the composition and active ingredients of all substances concerned and dismissed the appeal. As Ancare did not participate in the appeal, no order for costs was made.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established